Multiomics Market Size & Share Analysis - Growth, Trends, And Forecasts (2025 - 2030)

The Multiomics Market report segments the industry into By Product (Instruments, Reagents, Other Products), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, and more), By Application, By End User, and Geography.

Multiomics Market Size

Compare market size and growth of Multiomics Market with other markets in Healthcare Industry

Multiomics Market Analysis

The Multiomics Market size is estimated at USD 3.58 billion in 2025, and is expected to reach USD 7.29 billion by 2030, at a CAGR of 15.26% during the forecast period (2025-2030).

The multiomics market is expected to grow rapidly due to the increasing demand for single-cell multiomics in new drug development and disease diagnostics. Companies are developing novel single-cell platforms to study and discover areas of immunology. Collectively, this method is transforming molecular cell biology research. Single-cell multi-omics technologies characterize cell states and actions by concurrently integrating various single-modality omics methods that profile the epigenome, transcriptome, proteome, genome, epitranscriptome, metabolome, and other omics. For instance, in February 2023, BD (Becton, Dickinson, and Company) introduced a single-cell multiomics platform, BD Rhapsody HT Xpress System, to help in scientific discovery in various fields, including genetic disease research, immunology, cancer and chronic disorder research.

The increasing interest among researchers in single-cell genomics is also expected to boost the market demand as single-cell genomics can facilitate novel treatments for cardiovascular diseases (CVDs). For instance, in March 2023, the National Library of Medicine published research stating that single-cell genomics had wide applications in cardiovascular disorder research. It can be utilized in heart development, myocardial infarction (MI), cardiac ischemia-reperfusion (I/R) injury, atherosclerosis, atrial fibrillation, cardiac hypertrophy, and heart failure. Thus, with the increasing CVDs, the demand for single-cell genomics is also expected to increase significantly, driving the market’s growth.

The demand for multiomics in personalized medicine is growing as it is widely used to develop therapeutic strategies and knowledge bases for predictive and personalized medicine. In the future, the demand for multiomics in the field of personalized medicine is expected to be driven explicitly by the role of multiomics in diagnostic and prognostic biomarkers and its importance in pharmacological treatment.

However, the high cost of single-cell analysis and the challenges and complexity in multiomics data integration may pose a challenge to market growth in the near future.

Multiomics Industry Overview

The multiomics market is moderately consolidated in nature due to the presence of several companies operating globally as well as regionally. The market's key players occupy a significant share. However, many small companies are entering the market with the help of investors and developing new technologies. In the coming years, market competitiveness is expected to increase due to the entrance of new players. Some of the key companies in the multiomics market include BD, Bruker, DH Life Sciences, LLC, Illumina Inc., and Thermo Fisher Scientific Inc.

Multiomics Market Leaders

  1. BD

  2. Bruker

  3. Illumina, Inc

  4. DH Life Sciences, LLC

  5. Thermo Fisher Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Multiomics Market News

  • February 2024: Vizzhy Inc. launched the world's inaugural Multiomics Lab in Bengaluru, India, heralding a major advancement in healthcare innovation. Equipped with cutting-edge tools and health AI technology, the lab enables physicians to pinpoint root causes and offer personalized recommendations for their patients.
  • September 2023: MGI, a provider of technology and tools for life science, introduced the DCS Lab Initiative to stimulate crucial scientific research. This initiative encourages large-scale multiomics laboratories. Under the initiative, the organization offers products for numerous applications, including cell omics, DNA sequencing, and spatial omics based on DNBSEQ technologies, to specified research institutions globally.
  • April 2023: Biomodal, formerly Cambridge Epigenetix, introduced a new duet multiomics solution that can enable simultaneous phased reading of epigenetic and genetic information in a single, low-volume sample.

Multiomics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Single-cell Multiomics and Advancements in Omics Technologies
    • 4.2.2 Increasing Investment in Genomics R&D
    • 4.2.3 Growing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Single Cell Analysis
    • 4.3.2 Challenges in Multiomics data Integration and Complexity
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Reagents
    • 5.1.3 Other Products
  • 5.2 By Type
    • 5.2.1 Single-cell Multiomics
    • 5.2.2 Bulk Multiomics
  • 5.3 By Platform
    • 5.3.1 Genomics
    • 5.3.2 Transcriptomics
    • 5.3.3 Proteomics
    • 5.3.4 Metabolomics
    • 5.3.5 Integrated Omics Platforms
    • 5.3.6 Other Platforms
  • 5.4 By Application
    • 5.4.1 Cell Biology
    • 5.4.2 Oncology
    • 5.4.3 Neurology
    • 5.4.4 Immunology
    • 5.4.5 Other Applications
  • 5.5 By End User
    • 5.5.1 Academic and Research Institutes
    • 5.5.2 Pharmaceutical & Biotechnology Companies
    • 5.5.3 Other End Users
  • 5.6 Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 BD
    • 6.1.3 BGI
    • 6.1.4 Bruker
    • 6.1.5 DH Life Sciences LLC
    • 6.1.6 Illumina Inc.
    • 6.1.7 Mission Bio
    • 6.1.8 NanoCellect Biomedical
    • 6.1.9 PerkinElmer Inc.
    • 6.1.10 QIAGEN
    • 6.1.11 Shimadzu Corporation
    • 6.1.12 Singleron Biotechnologies
    • 6.1.13 Standard BioTools
    • 6.1.14 Thermo Fisher Scientific Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products, and Strategies and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Multiomics Industry Segmentation

Multiomics (multiple omics) specifies an integrated method to power breakthroughs across several levels of biology. Multiomics is mainly used to study the complete genetic or molecular profiles of humans and other organisms by combining the multiple levels of molecular biology.

The multiomics market is segmented into product, type, platform, application, end user, and geography. By product, the market is segmented into instruments, reagents, and other products. The other products include consumables and accessories. By type, the market is segmented into single-cell multiomics and bulk multiomics. By platform, the market is segmented into genomics, transcriptomics, proteomics, metabolomics, integrated omics platforms, and other platforms. The other platforms include epigenomics, radiomics, and microbiomes. By application, the market is segmented into cell biology, oncology, neurology, immunology, and other applications. The other applications include agriculture and plant physiology. By end user, the market is segmented into academic and research Institutes, pharmaceutical & biotechnology companies, and other end users. The other end users include scientific laboratories and hospitals. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (USD) for all the above segments.

By Product Instruments
Reagents
Other Products
By Type Single-cell Multiomics
Bulk Multiomics
By Platform Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
Other Platforms
By Application Cell Biology
Oncology
Neurology
Immunology
Other Applications
By End User Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product
Instruments
Reagents
Other Products
By Type
Single-cell Multiomics
Bulk Multiomics
By Platform
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
Other Platforms
By Application
Cell Biology
Oncology
Neurology
Immunology
Other Applications
By End User
Academic and Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Multiomics Market Research FAQs

How big is the Multiomics Market?

The Multiomics Market size is expected to reach USD 3.58 billion in 2025 and grow at a CAGR of 15.26% to reach USD 7.29 billion by 2030.

What is the current Multiomics Market size?

In 2025, the Multiomics Market size is expected to reach USD 3.58 billion.

Who are the key players in Multiomics Market?

BD, Bruker, Illumina, Inc, DH Life Sciences, LLC and Thermo Fisher Scientific Inc. are the major companies operating in the Multiomics Market.

Which is the fastest growing region in Multiomics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Multiomics Market?

In 2025, the North America accounts for the largest market share in Multiomics Market.

What years does this Multiomics Market cover, and what was the market size in 2024?

In 2024, the Multiomics Market size was estimated at USD 3.03 billion. The report covers the Multiomics Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Multiomics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on: November 13, 2024

Multiomics Industry Report

Statistics for the 2025 Multiomics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Multiomics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.